Newedge-Advisors

Filing Details

13F-HR • 2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
3,959
Total Value
16833614193
Accession Number
0001213900-25-043870
Form Type
13F-HR
Manager Name
Newedge-Advisors
Data Enrichment
66% identified
2,597 identified1,362 unidentified

Holdings

3,959 positions • $16.8B total value
Manager:
Search and click to pin securities to the top
Page 192 of 198
DOMO, INC.
Shares:20
Value:$155
% of Portfolio:0.0% ($155/$16.8B)
GALAPAGOS NV
Shares:6
Value:$151
% of Portfolio:0.0% ($151/$16.8B)
Lifeway Foods, Inc.
Shares:6
Value:$147
% of Portfolio:0.0% ($147/$16.8B)
Vir Biotechnology, Inc.
Shares:20
Value:$130
% of Portfolio:0.0% ($130/$16.8B)
Safety Shot, Inc.
Shares:335
Value:$122
% of Portfolio:0.0% ($122/$16.8B)
Mr. Cooper Group Inc.
Shares:1
Value:$120
% of Portfolio:0.0% ($120/$16.8B)
CHINA AUTOMOTIVE SYSTEMS INC
Shares:25
Value:$111
% of Portfolio:0.0% ($111/$16.8B)
ZimVie Inc.
Shares:10
Value:$108
% of Portfolio:0.0% ($108/$16.8B)
00768Y412
Shares:6
Value:$105
% of Portfolio:0.0% ($105/$16.8B)
PRECISION BIOSCIENCES INC
Shares:22
Value:$103
% of Portfolio:0.0% ($103/$16.8B)
MARAVAI LIFESCIENCES HOLDINGS, INC.
Shares:46
Value:$102
% of Portfolio:0.0% ($102/$16.8B)
Macy's, Inc.
Shares:8
Value:$100
% of Portfolio:0.0% ($100/$16.8B)
97717W471
Shares:3
Value:$91
% of Portfolio:0.0% ($91/$16.8B)
26923G301
Shares:5
Value:$88
% of Portfolio:0.0% ($88/$16.8B)
EASTMAN KODAK CO
Shares:14
Value:$88
% of Portfolio:0.0% ($88/$16.8B)
Humacyte, Inc.
Shares:50
Value:$85
% of Portfolio:0.0% ($85/$16.8B)
BIOCRYST PHARMACEUTICALS INC
Shares:11
Value:$83
% of Portfolio:0.0% ($83/$16.8B)
EKSO BIONICS HOLDINGS, INC.
Shares:200
Value:$81
% of Portfolio:0.0% ($81/$16.8B)
EchoStar CORP
Shares:3
Value:$77
% of Portfolio:0.0% ($77/$16.8B)
Esquire Financial Holdings, Inc.
Shares:1
Value:$76
% of Portfolio:0.0% ($76/$16.8B)